share_log

Earnings Growth Outpaced the 25% Return Delivered to HealthStream (NASDAQ:HSTM) Shareholders Over the Last Year

Earnings Growth Outpaced the 25% Return Delivered to HealthStream (NASDAQ:HSTM) Shareholders Over the Last Year

收入增長超過了過去一年爲健康流科技(納斯達克:HSTM)股東帶來的25%回報。
Simply Wall St ·  11/07 05:44

We believe investing is smart because history shows that stock markets go higher in the long term. But if when you choose to buy stocks, some of them will be below average performers. Unfortunately for shareholders, while the HealthStream, Inc. (NASDAQ:HSTM) share price is up 24% in the last year, that falls short of the market return. However, the stock hasn't done so well in the longer term, with the stock only up 16% in three years.

我們相信投資是明智的,因爲歷史顯示股市從長遠來看會走高。但當你選擇買入股票時,有些股票表現會低於平均水平。遺憾的是,儘管在過去一年中HealthStream, Inc. (NASDAQ:HSTM)的股價上漲了24%,但仍不及市場回報。然而,股票在更長期內表現不佳,三年內僅上漲了16%。

The past week has proven to be lucrative for HealthStream investors, so let's see if fundamentals drove the company's one-year performance.

過去一週對HealthStream的投資者來說是有利可圖的,讓我們看看是不是基本面推動了公司一年的表現。

To paraphrase Benjamin Graham: Over the short term the market is a voting machine, but over the long term it's a weighing machine. One way to examine how market sentiment has changed over time is to look at the interaction between a company's share price and its earnings per share (EPS).

用本傑明·格雷厄姆的話來說:「短期市場是一臺投票機,但長期市場是一臺稱重機」。檢查市場情緒如何隨時間推移變化的一種方式是查看公司股價和每股收益(EPS)之間的相互作用。

HealthStream was able to grow EPS by 52% in the last twelve months. This EPS growth is significantly higher than the 24% increase in the share price. So it seems like the market has cooled on HealthStream, despite the growth. Interesting.

HealthStream在過去十二個月內EPS增長了52%。這種EPS增長明顯高於24%的股價漲幅。因此,市場似乎對HealthStream失去了興趣,儘管有增長。有趣。

You can see below how EPS has changed over time (discover the exact values by clicking on the image).

您可以看到EPS隨時間的變化如下(通過單擊圖像了解確切數值)。

big
NasdaqGS:HSTM Earnings Per Share Growth November 7th 2024
納斯達克GS:HSTm2024年11月7日每股收益增長

It's probably worth noting that the CEO is paid less than the median at similar sized companies. But while CEO remuneration is always worth checking, the really important question is whether the company can grow earnings going forward. Before buying or selling a stock, we always recommend a close examination of historic growth trends, available here..

值得注意的是,該公司CEO薪酬低於同等規模公司的中位數。但是,雖然CEO薪酬值得檢查,但真正重要的問題是該公司未來能否增長收益。在購買或出售股票之前,我們始終建議對歷史增長趨勢進行仔細檢查。點擊此處可獲得有關歷史增長趨勢的信息。

A Different Perspective

另一種看法

HealthStream shareholders are up 25% for the year (even including dividends). But that return falls short of the market. On the bright side, that's still a gain, and it's actually better than the average return of 3% over half a decade It is possible that returns will improve along with the business fundamentals. I find it very interesting to look at share price over the long term as a proxy for business performance. But to truly gain insight, we need to consider other information, too. For example, we've discovered 1 warning sign for HealthStream that you should be aware of before investing here.

健康流科技的股東今年股價上漲了25%(甚至包括分紅)。 但這個回報還不及市場。 但好消息是,這仍然是一筆收益,實際上比過去半個世紀3%的平均回報要好。 可能隨着業務基本面的改善,回報也會提高。 我發現長期觀察股價作爲業務表現的一種替代方法非常有趣。 但要真正獲得洞察力,我們也需要考慮其他信息。 例如,我們已經發現了健康流科技的1個警示信號,您在這裏投資之前應該注意。

We will like HealthStream better if we see some big insider buys. While we wait, check out this free list of undervalued stocks (mostly small caps) with considerable, recent, insider buying.

如果我們看到一些大規模內部買入行爲,我們會更喜歡健康流科技。 當我們等待時,請查看這份免費的被低估股票名單(主要是小市值公司),其中包含大量最近的內部買入交易。

Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on American exchanges.

請注意,本文所引述的市場回報反映了目前在美國交易所上市的股票的市場加權平均回報。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對這篇文章有反饋嗎?對內容感到擔憂嗎?請直接與我們聯繫。或者,發送電子郵件至editorial-team @ simplywallst.com。
Simply Wall St的這篇文章是一般性質的。我們僅基於歷史數據和分析師預測提供評論,使用公正的方法,我們的文章並非意在提供財務建議。這並不構成買入或賣出任何股票的建議,並且不考慮您的目標或財務狀況。我們旨在爲您帶來基於基礎數據驅動的長期聚焦分析。請注意,我們的分析可能未考慮最新的價格敏感公司公告或定性材料。Simply Wall St對提及的任何股票都沒有持倉。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論